HCPCS Level II · Outpatient PPS (temporary codes)
C9089Bupivacaine, collagen-matrix implant, 1 mg
Terminated 12/31/2025
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9089
C9089 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing bupivacaine, collagen-matrix implant, 1 mg.
It was added to HCPCS effective 01/01/2022, and its current record took effect 01/01/2026.
It was terminated on 12/31/2025 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Bupivacaine implant, 1 mg
- Date added
- 01/01/2022
- Action effective
- 01/01/2026
- Termination date
- 12/31/2025
- BETOS
- O1E
Related C90xx codes
Common questions about C9089
Is HCPCS C9089 still valid?
- No. C9089 was terminated on 12/31/2025.
Does Medicare cover C9089?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.